Lv1
35 积分 2021-07-15 加入
Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2
1天前
已完结
Review of the impact of fragment-based drug design on PROTAC degrader discovery
9天前
已完结
Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer
18天前
已完结
Structural Feature Analyzation Strategies toward Discovery of Orally Bioavailable PROTACs of Bruton’s Tyrosine Kinase for the Treatment of Lymphoma
18天前
已完结
Improved efficiency and selectivity in peptide synthesis: Use of triethylsilane as a carbocation scavenger in deprotection of t-butyl esters and t-butoxycarbonyl-protected sites
30天前
已完结
Improved efficiency and selectivity in peptide synthesis: Use of triethylsilane as a carbocation scavenger in deprotection of t-butyl esters and t-butoxycarbonyl-protected sites
1个月前
已完结
Early Process Development of CH7057288, a Benzofuran-Containing Selective NTRK Inhibitor
1个月前
已完结
Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
1个月前
已完结
Controlled Refolding of Denatured IL‐12 Using In Situ Antigen‐Capturing Nanochaperone Remarkably Reduces the Systemic Toxicity and Enhances Cancer Immunotherapy
1个月前
已完结
Synergizing CXCL9 with BRD4‐PROTAC Using Nanochaperone Boosts Robust T Cell‐Dependent Antitumor Immune Responses for Cancer Immunotherapy
1个月前
已完结
皖公网安备34019202002308
